Korean Tickers
KRX in English
HomeMarketsStocksFinancialsGuide
NewsfeedInsightsEarningsBroker research
AI Value ChainAPI overviewPricingDocumentationPlan & billing
X
Korean Tickers
KRX in English
HomeMarketsStocksFinancialsGuide
NewsfeedInsightsEarningsBroker research
AI Value ChainAPI overviewPricingDocumentationPlan & billing
XSign in

Market Pulse

Awaiting market data · data.go.kr + ECOS
KOSPI
—
KOSDAQ
—
KOSPI 200
—
USD/KRW
—
Home›Stocks›354200
Key statistics
Korean Tickers·Research reference for Korean listed companies.
API overviewPricingDocumentationPlan & billing
Prices use KIS quote snapshots with data.go.kr daily fallback. Financials use DART; macro data uses ECOS.·Market data is informational and not investment advice.
KIS snapshots are refreshed every 30 minutes and are not a streaming quote feed.·Sources
TermsRefundsDisclaimerPrivacy
Home›Stocks›354200
← Back to search
KRX · 354200

NGeneBio Co., Ltd.

$0.5145
$-0.0391 (-7.07%)
₩710 · data.go.kr daily snapshot
NGeneBio Co., Ltd.

354200 is the Korean stock ticker for NGeneBio Co., Ltd., a KOSDAQ-listed Korean public company in Business Services & Distribution.

Business activities
  • Precision diagnostics
  • ·Property leasing
Products & services
  • Precision diagnostic products
  • ·Research services
Source: DART annual filing (opens in a new tab)
KOSDAQ
data.go.kr daily public data for prices and market data. Updated after the next trading day.
Key statistics
Market cap
$8.28M
₩11.4B
52w high / low
$0.6094 / $0.5109
₩841 / ₩705
Listed shares
16.09M
P/E
N/A
P/B
N/A
YTD
-51.83%
First trading day close
Volume $
$387.0K
₩534.1M
EPS
N/A
BPS
N/A
Previous close
$0.5536
₩764

Advertisement

Loading financials...
Loading annual trend...
Loading disclosures...
Loading DART earnings brief...

Company profile

Market
Ticker
Instrument
Industry group
Legal name
Listed date
Reports

Broker and public research

All for ticker →

Advertisement

Quick reference

Common questions about NGeneBio Co., Ltd.

Copy-ready stock summary›
  • NGeneBio Co., Ltd. (354200) is a KOSDAQ-listed common share on KRX, Korean name: 엔젠바이오, sector: Business Services & Distribution, official industry: Other Professional, Scientific and Technical Services.
  • Latest daily public-data snapshot dated 2026-10-06: close price KRW 710, USD 0.5145, daily change -7.07%, volume 702,937 shares.
  • Valuation snapshot: market cap KRW 11.4B (USD 8.28M), listed shares 16.09M shares, P/B 0.61x.
  • Latest DART periodic filing: Half-year report for 2026.06, filed on 2026-08-14, receipt number 20260814001214.
  • Price-sensitive valuation fields use the latest retained daily public-data close with confirmed DART TTM or annual facts; unavailable values are omitted rather than shown as zero.
What is NGeneBio Co., Ltd. (354200)?›

354200 is the Korean stock ticker for NGeneBio Co., Ltd., a KOSDAQ-listed Korean public company in Business Services & Distribution. Business activity: Precision diagnostics. Business activity: Property leasing. Product/service: Precision diagnostic products. Product/service: Research services.

DART disclosures

Earnings reports

Annual, half-year, and quarterly financial reports
10-K / 10-Q analog
  • 2026-08-14
    Half-Year Report (2026 H1)
    DART filing· 20260814001214
  • 2026-05-15
    Quarterly Report (2026 Q1)
    DART filing· 20260515002053
  • 2026-03-23
    Annual Report (2025 FY)
    DART filing· 20260323001424
  • 2025-11-13
    Quarterly Report (2025 Q3)
    DART filing· 20251113000419
  • 2025-08-14
    Half-Year Report (2025 H1)
    DART filing· 20250814002989
  • 2025-05-15
    Quarterly Report (2025 Q1)
    DART filing· 20250515002310
  • 2025-03-21
    Annual Report (2024 FY)
    DART filing· 20250321001896
  • 2024-11-14
    Quarterly Report (2024 Q3)
    DART filing· 20241114002466
  • 2024-08-14
    Half-Year Report (2024 H1)
    DART filing· 20240814003649
  • 2024-05-14
    Quarterly Report (2024 Q1)
    DART filing· 20240514001493
  • 2024-03-20
    Annual Report (2023 FY)
    DART filing· 20240320001877

Company profile

MarketKOSDAQ
Ticker354200
InstrumentCommon share
Industry groupBusiness Services & Distribution
Official industryOther Professional, Scientific and Technical Services
Business activitiesDisplay Panels · Pharmaceuticals
ISIN-
Legal name엔젠바이오
Representative-
Listed date-
Employees-
FSS corp code-
Market cap$8.28M / ₩11.4B
Data sourcesdata.go.kr · DART · ECOS
Company basics and prices use data.go.kr public-data APIs.

Market Pulse

Daily · Oct 6, 2026 · data.go.kr + ECOS
KOSPI
6,941.39
-62.35 (-0.89%)
KOSDAQ
919.92
+26.63 (+2.98%)
KOSPI 200
1,095.83
-13.22 (-1.19%)
USD/KRW
1,343.60

Financial trend (USD)

DART CFS
RevenueAnnual · USD reference
$4.12M
2024
$15.39M
2025
Operating incomeAnnual · USD reference
$-11.65M
2024
$-6.00M
2025
EPS2026 Q2 TTM · CFS · 6 DART filings · close 2026-10-06 · latest daily listed shares
$-0.2390
TTM
Business Services & Distribution
USD reference view
Market cap
$8.28M
Day range
$0.5109 / $0.6094
52w gain
Loading
Industry group: Business Services & Distribution
Official industry: Other Professional, Scientific and Technical Services
Display PanelsPharmaceuticals
Day range
$0.5109 / $0.6094
₩705 / ₩841
52w gain
+0.71%
Vs 52w high -15.58%
No reports tracked yet

This ticker has no publisher-linked research report in the current collection.

Earnings calendar

Earnings releases and reports

No upcoming earnings release notice is currently loaded.
Next earnings report
Nov 16, 2026
Estimated · Quarterly earnings report · 2026.09
Latest earnings report
Aug 14, 2026
Half-year earnings report · 2026.06
FX reference: 1 USD ≈ ₩1380.00 · manual fallback until ECOS is available. This page is for reference only and is not investment advice.
Where does 354200 trade?›

354200 is a Korean stock ticker that trades on KOSDAQ as a common share tracked by Korean Tickers with data.go.kr daily public data, DART filings, and USD reference values.

What sector is NGeneBio Co., Ltd. in?›

NGeneBio Co., Ltd. is classified by Korean Tickers under Business Services & Distribution, with official issuer and industry context shown on the company profile.

Source stack: data.go.kr public records, DART, English OpenDART, and ECOS. Price data is a daily public-data file.
Insights

Articles mentioning this ticker

No linked insight articles yet.
Links open the original writer page.
News links

Latest external coverage

Title and original source link only.
External news links are unavailable right now.
Indexed via Korean Tickers source directoryMore

Financials

Consolidated · DART · standalone quarters and annual history
Financial details →
Revenue, profit, and cash flow use standalone three-month quarters. Balance-sheet rows use period-end snapshots.
Copy-ready financial summary›
  • Latest annual DART consolidated financials for NGeneBio Co., Ltd. (ticker 354200) (2025 annual report): revenue was KRW 21.2B, op was -KRW 8.28B, and net was -KRW 6.76B.
  • Annual balance sheet snapshot (2025 annual report): assets was KRW 72.3B, liabilities was KRW 49.7B, equity was KRW 22.6B, and cash was KRW 1.94B.
  • Latest three-month quarterly DART financials (2026 second quarter): revenue was KRW 12.5B, op was -KRW 1.19B, and net was -KRW 3.46B.
  • Source filings: 2025 annual report: DART filing 20260323001424; 2026 second quarter: DART filing 20260814001214.
  • Unavailable DART metrics are omitted rather than shown as zero.
DART earnings brief

2026 Q2 Consolidated earnings

Date pending · Half-Year Report (2026 H1)
DART source →
Revenue
₩12.5B
Operating income
-₩1.19B
Net income
-₩3.46B
Operating cash flow
-₩1.43B
Movement
  • Revenue was ₩12.5B, up 4.2% QOQ.
  • Operating cash flow was -₩1.4B, down 240.4% QOQ.
  • Capex was ₩19.3M, down 97.5% QOQ.
  • Operating income was -₩1.2B, up 24.3% QOQ.
  • Net income was -₩3.5B, up 17.7% QOQ.
  • Inventory was ₩1.7B, up 4.6% QOQ.
2024 Q12024 Q22024 Q32024 Q42025 Q12025 Q22025 Q3FY 20252026 Q12026 Q2
Quarterly flow

Revenue and profit trend

Indexed to first shown quarter = 100
Indexed trend
RevenueOperating incomeNet income
1550646-25924 Q124 Q224 Q324 Q425 Q1
P/S
0.27x
2026 Q2 TTM · daily close 20261006 · CFS · 6 DART filings
Operating margin
-13.1%
2026 Q2 TTM · CFS · 6 DART filings
Revenue growth
+96.6%
2026 Q2 TTM vs 2025 FY
ROE
-29.2%
2026 Q2 TTM / average comparable equity
Debt / equity
2.78x
ROA
-10.4%
2026 Q2 TTM / average comparable assets
Asset turnover
0.82x
Gross margin
+13.8%
Current ratio
0.45x
Cash balance
$2.17M
₩3.0B
Cash / mkt cap
+26.3%
Item
TTM
26 Q2 LTM / latest balance sheet
26 Q2
Standalone quarter
26 Q1
Standalone quarter
2025
Annual
2024
Annual
Change
vs 2025
Revenue
$30.26M
₩41.8B
$9.02M
₩12.5B
$8.66M
₩12.0B
$15.39M
₩21.2B
$4.12M
₩5.7B
+96.6%
Gross Profit
$4.18M
₩5.8B
$1.38M
₩1.9B
$1.02M
₩1.4B
$2.75M
₩3.8B
$1.55M
₩2.1B
+51.8%
Operating Income
$-3.98M
₩-5.5B
$-859K
₩-1.2B
$-1.13M
₩-1.6B
$-6.00M
₩-8.3B
$-11.65M
₩-16.1B
+33.7%
Net Income
$-3.84M
₩-5.3B
$-2.51M
₩-3.5B
$-3.05M
₩-4.2B
$-4.90M
₩-6.8B
$-10.10M
₩-13.9B
+21.5%
Cash & Equivalents
$2.17M
₩3.0B
$2.17M
₩3.0B
$2.15M
₩3.0B
$1.41M
₩1.9B
$3.21M
₩4.4B
+54.4%
Current Assets
$16.46M
₩22.7B
$16.46M
₩22.7B
$16.86M
₩23.3B
$17.70M
₩24.4B
$8.46M
₩11.7B
-7.0%
Receivables
$9.42M
₩13.0B
$9.42M
₩13.0B
$8.97M
₩12.4B
$10.09M
₩13.9B
$552K
₩761.8M
-6.6%
Inventory
$1.20M
₩1.7B
$1.20M
₩1.7B
$1.15M
₩1.6B
$1.03M
₩1.4B
$1.50M
₩2.1B
+16.8%
Total Assets
$51.18M
₩70.6B
$51.18M
₩70.6B
$51.95M
₩71.7B
$52.42M
₩72.3B
$23.88M
₩32.9B
-2.4%
Current Liabilities
$36.76M
₩50.7B
$36.76M
₩50.7B
$34.94M
₩48.2B
$34.82M
₩48.0B
$9.08M
₩12.5B
+5.6%
Total Liabilities
$37.64M
₩51.9B
$37.64M
₩51.9B
$35.92M
₩49.6B
$36.05M
₩49.7B
$11.04M
₩15.2B
+4.4%
Total Equity
$13.54M
₩18.7B
$13.54M
₩18.7B
$16.03M
₩22.1B
$16.37M
₩22.6B
$12.83M
₩17.7B
-17.3%
25 Q225 Q3FY 202526 Q126 Q2
Revenue
₩12.5B
+4.2% QoQ
Operating income
-₩1.19B
+24.3% QoQ
Net income
-₩3.46B
+17.7% QoQ
1Y price trend
data.go.kr daily close and volume · USD reference · data.go.kr daily snapshot · Updated after the next trading day · stale cache
$0.5536
$-0.7058 (-56.04%)
₩764
$2.19$1.74$1.30$0.8550$0.4108USDVol.25/09/3025/11/0326/01/0226/03/0326/05/0426/07/0126/09/0126/10/0210.1M5.1M0
-3.53%
Key statistics
Market cap
$8.28M
₩11.4B
52w high / low
$2.065 / $0.5333
₩2,850 / ₩736
Listed shares
16.09M
P/E
N/M
2026 Q2 TTM · daily close 2026-10-06 · CFS · 6 DART filings · non-positive earnings
P/B
0.61x
Daily close 2026-10-06
YTD
-51.83%
First trading day close
Volume $
$387.0K
₩534.1M
EPS
$-0.2390
₩-329.799 · 2026 Q2 TTM · daily close 2026-10-06 · CFS · 6 DART filings
BPS
$0.8417
₩1,161.603
Previous close
$0.5536
₩764
Day range
$0.5109 / $0.6094
₩705 / ₩841
52w gain
-3.53%
Vs 52w high -75.09%